{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:40:13Z","timestamp":1782124813870,"version":"3.54.5"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[1987,12,1]],"date-time":"1987-12-01T00:00:00Z","timestamp":565315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1987,12,1]],"date-time":"1987-12-01T00:00:00Z","timestamp":565315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1987,12]]},"DOI":"10.1007\/bf00207261","type":"journal-article","created":{"date-parts":[[2004,9,3]],"date-time":"2004-09-03T03:31:46Z","timestamp":1094182306000},"page":"S35-S40","source":"Crossref","is-referenced-by-count":24,"title":["Interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma"],"prefix":"10.1007","volume":"5","author":[{"given":"Teodoro","family":"Chisesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Capnist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Vespignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Cetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF00207261_CR1","first-page":"25","volume":"20","author":"CS Portlock","year":"1983","unstructured":"Portlock CS: \u201cGood risk\u201d non-Hodgkin's lymphomas: Approaches to management. Sem Haematol 20:25, 1983","journal-title":"Sem Haematol"},{"key":"BF00207261_CR2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/bmj.1.6112.553","volume":"1","author":"TA Lister","year":"1978","unstructured":"Lister TA, Cullen MH, Beard MEJ: Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type. Br Med J 1:553, 1978","journal-title":"Br Med J"},{"key":"BF00207261_CR3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/1097-0142(197801)41:1<23::AID-CNCR2820410106>3.0.CO;2-Y","volume":"41","author":"T Kennedy","year":"1978","unstructured":"Kennedy T, Bloomfield CD, Kiang DT: Combination versus successive single agent chemotherapy in lymphocytic lymphoma. Cancer 41:223, 1978","journal-title":"Cancer"},{"key":"BF00207261_CR4","first-page":"377","volume":"66","author":"R Bell","year":"1982","unstructured":"Bell R, Gallagher CJ, Ford J, Malpas JS, Lister TA: Phase III study of high-dose regimen of cyclophosphamide and prednisolone in advanced non-Hodgkin's lymphoma of favourable histologic type. Cancer Tr Rif 66:377, 1982","journal-title":"Cancer Tr Rif"},{"key":"BF00207261_CR5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/1097-0142(19850915)56:6<1305::AID-CNCR2820560614>3.0.CO;2-N","volume":"56","author":"SJ Horning","year":"1985","unstructured":"Horning SJ, Merigan TC, Krown SE: Human interferon alpha in malignant lymphoma and Hodgkin's disease. Cancer 56:1305, 1985","journal-title":"Cancer"},{"key":"BF00207261_CR6","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198411013111803","volume":"311","author":"KA Foon","year":"1984","unstructured":"Foon KA, Sherwin SA, Aprams PG: Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon. N Eng J Med 311:1148, 1984","journal-title":"N Eng J Med"},{"key":"BF00207261_CR7","unstructured":"Wagstaff J, Crowther D: Human alpha-2 interferon in the treatment of both previously treated and untreated patients with low grade non-Hodgkin's lymphoma. Cancer Chemoth Pharmacol (in press)"},{"key":"BF00207261_CR8","unstructured":"Rohatiner AZS, Richards MA, Barnet MJ, Stanfeld AG, Lister TA: Chlorambucil and interferon in patients with low-grade non-Hodgkin's lymphoma. Br J Haem (in press)"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00207261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00207261\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00207261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00207261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T17:38:48Z","timestamp":1678556328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00207261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,12]]},"references-count":8,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[1987,12]]}},"alternative-id":["BF00207261"],"URL":"https:\/\/doi.org\/10.1007\/bf00207261","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,12]]}}}